Skin Cancer Diagnosis and Therapeutics Market
Skin Cancer Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Cancer Type (Melanoma, and Non-Melanoma), by Diagnosis Type (Dermatoscopy, Biopsy, Imaging Techniques, Molecular Diagnostics, and Blood Tests), by Therapeutic Type (Surgical Procedures, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Photodynamic Therapy, Topical Treatments, and Others), and by End User (Hospitals, Specialty Dermatology Clinics, Cancer Treatment Centers, Ambulatory Surgical Centers, Diagnostic Laboratories, and Research & Academic Institutes) Forecast Period (2025-2035)
Industry Overview
Skin cancer diagnosis and therapeutics market was valued at $14,258 million in 2024 and is projected to reach $25,160 million by 2035, growing at a CAGR of 5.3% from 2025 to 2035. The companies are utilizing AI and imaging technologies to improve early detection, reduce costs, and decrease dermatologist reliance, thereby driving market growth in underserved regions. For instance, in April 2025, British HealthTech company Skin Analytics secured $18.3 million in Series B funding from Intrepid Growth Partners to expand its AI skin cancer detection technology, DERM, to Europe, Australia, and the US market. The investment follows Skin Analytics' EU MDR Class III CE mark approval, making DERM the world's first legally authorized AI medical device to independently make clinical decisions on skin cancer without human review.
Market Dynamics
Rising Incidence of Skin Cancer
The rise in skin cancer rates due to UV exposure, tanning habits, and aging populations is driving global market expansion and growth in the US market. According to the American Academy of Dermatology Association, in March 2025, Skin cancer ranks as the most prevalent cancer in the US, with current estimates indicating that one in five Americans will develop it during their lifetime. Each day, around 9,500 individuals in the US receive a skin cancer diagnosis, and over 1 million Americans are currently living with melanoma. By 2025, it is projected that there will be 212,200 new melanoma cases, including 107,240 noninvasive and 104,960 invasive cases, with invasive melanoma expected to be the fifth most common cancer diagnosis for both men (60,550 cases) and women (44,410 cases).
Shortage of Dermatologists and Healthcare Personnel
The global dermatology shortage is causing a surge in the use of automated diagnostic tools, especially in underserved and rural areas, thereby driving market growth through AI-enabled decision support systems. For instance, in April 2025, Skin Analytics raised $16.1 million to develop AI skin cancer detection technology, DERM which is the globe's first legally authorized device to make clinical decisions on skin cancer without human review. The funds will be used to expand the company's focus and launch products for all dermatology concerns, in addition to expanding internationally to key markets such as Europe and Australia. The investment comes amid dermatologist shortages worldwide, with DERM already transforming dermatology in the UK, reducing unnecessary face-to-face appointments by up to 95%.
Market Segmentation
- Based on the cancer type, the market is segmented into melanoma and non-melanoma.
- Based on the diagnosis type, the market is segmented into dermatoscopy, biopsy, imaging techniques, molecular diagnostics, and blood tests.
- Based on the therapeutic type, the market is segmented into surgical procedures, radiation therapy, chemotherapy, targeted therapy, immunotherapy, photodynamic therapy, topical treatments, and others (laser therapy, and vaccine therapy).
- Based on the end user, the market is segmented into hospitals, specialty dermatology clinics, cancer treatment centers, ambulatory surgical centers, diagnostic laboratories, and research & academic institutes.
Non-Melanoma Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC): A Key Segment in Market Growth
The increasing global skin cancer incidence, influenced by factors such as UV exposure, ozone depletion, and outdoor lifestyles, is causing a need for enhanced diagnostic and therapeutic solutions. According to the American Cancer Society, org, in October 2023, skin cancers, primarily basal and squamous cell types, are the most frequently diagnosed cancers in the United States. Annually, approximately 5.4 million cases are reported, affecting about 3.3 million individuals, as many have multiple occurrences, with basal cell cancers comprising about 80% of these cases. Although the incidence of these cancers has been rising due to improved detection, increased sun exposure and longer life spans, the mortality rate remains relatively low, with estimated deaths ranging from 2,000 to 8,000 each year.
Regional Outlook
The global skin cancer diagnosis and therapeutics market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
Demand for Precision Medicine in Asia-Pacific
The market growth is attributed to increased awareness, early detection, and technological advancements in diagnostics and treatment. For instance, in February 2024, AIIMS Delhi introduced Mohs micrographic surgery, an advanced technique for treating skin cancer, marking a significant development in India's healthcare sector. The surgery involves layer-by-layer removal of cancerous tissue, preserving healthy tissue, and reducing the chance of recurrence. The facility, supported by six surgeons and three technicians from the USA, offers world-class care without international travel.
North America Region Dominates the Market with Major Share
North America holds a significant share, owing to the government and institutional support that is driving global growth in skin cancer screening programs and AI-based health innovations, with FDA regulatory approvals boosting the assurance of consumers and healthcare professionals. For instance, in January 2024, the FDA approved DermaSensor, the first AI-powered skin cancer diagnostic tool, for noninvasive, quantitative identification of skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma. The device uses spectroscopy technology to examine lesions at cellular and subcellular levels, demonstrating a 96% sensitivity across all 224 types of skin cancers and a 97% chance of benign results.
Market Players Outlook
The major companies operating in the global skin cancer diagnosis and therapeutics market include Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In March 2025, Sun Pharma planned to purchase US-based oncology firm Checkpoint for $355 million, acquiring UNLOXCYT, a skin cancer treatment product approved by the FDA for treating adults with metastatic cutaneous squamous cell carcinoma.
- In April 2025, the NHS launched a skin cancer vaccine trial for advanced patients, part of the CVLP program, and accelerating access to mRNA vaccine clinical trials for various cancer types. The CVLP is expanding its scope to include melanoma, a serious form of skin cancer, to provide personalized treatments to up to 10,000 patients in England by 2030, demonstrating the NHS's commitment to innovative cancer therapies.
The Report Covers
- Market value data analysis for 2024 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global skin cancer diagnosis and therapeutics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Global Skin Cancer Diagnosis and Therapeutics Market Sales Analysis – Cancer Type | Diagnosis Type | Therapeutic Type | End User ($ Million)
• Skin Cancer Diagnosis and Therapeutics Market Sales Performance of Top Countries
1.1. Research Methodology
• Primary Research Approach
• Secondary Research Approach
1.2. Market Snapshot
2. Market Overview and Insights
2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Skin Cancer Diagnosis and Therapeutics Industry Trends
2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Skin Cancer Diagnosis and Therapeutics Market
2.3.1. Competitive Rivalry
2.3.2. Threat of New Entrants
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Substitutes
3. Market Determinants
3.1. Market Drivers
3.1.1. Drivers For Global Skin Cancer Diagnosis and Therapeutics Market: Impact Analysis
3.2. Market Pain Points and Challenges
3.2.1. Restraints For Global Skin Cancer Diagnosis and Therapeutics Market: Impact Analysis
3.3. Market Opportunities
4. Competitive Landscape
4.1. Competitive Dashboard – Skin Cancer Diagnosis and Therapeutics Market Revenue and Share by Manufacturers
• Skin Cancer Diagnosis and Therapeutics Product Comparison Analysis
• Top Market Player Ranking Matrix
4.2. Key Company Analysis
4.2.1. Amgen Inc.
4.2.1.1. Overview
4.2.1.2. Financial Analysis
4.2.1.3. SWOT Analysis
4.2.1.4. Recent Developments
4.2.2. Bristol-Myers Squibb Co.
4.2.2.1. Overview
4.2.2.2. Financial Analysis
4.2.2.3. SWOT Analysis
4.2.2.4. Recent Developments
4.2.3. F. Hoffmann-La Roche Ltd
4.2.3.1. Overview
4.2.3.2. Financial Analysis
4.2.3.3. SWOT Analysis
4.2.3.4. Recent Developments
4.2.4. Merck & Co., Inc.
4.2.4.1. Overview
4.2.4.2. Financial Analysis
4.2.4.3. SWOT Analysis
4.2.4.4. Recent Developments
4.2.5. Sun Pharmaceutical Industries Ltd.
4.2.5.1. Overview
4.2.5.2. Financial Analysis
4.2.5.3. SWOT Analysis
4.2.5.4. Recent Developments
4.3. Key Strategy Analysis
5. Global Skin Cancer Diagnosis and Therapeutics Market by Cancer Type ($ Million)
5.1.1. Melanoma
5.1.2. Non-Melanoma
6. Global Skin Cancer Diagnosis and Therapeutics Market by Diagnosis Type ($ Million)
6.1.1. Dermatoscopy
6.1.2. Biopsy
6.1.3. Imaging Techniques
6.1.4. Molecular Diagnostics
6.1.5. Blood Tests
7. Global Skin Cancer Diagnosis and Therapeutics Market by Therapeutic Type ($ Million)
7.1.1. Surgical Procedures
7.1.2. Radiation Therapy
7.1.3. Chemotherapy
7.1.4. Targeted Therapy
7.1.5. Immunotherapy
7.1.6. Photodynamic Therapy
7.1.7. Topical Treatments
7.1.8. Others (Laser Therapy, and Vaccine Therapy)
8. Global Skin Cancer Diagnosis and Therapeutics Market by End User ($ Million)
8.1.1. Hospitals
8.1.2. Specialty Dermatology Clinics
8.1.3. Cancer Treatment Centers
8.1.4. Ambulatory Surgical Centers
8.1.5. Diagnostic Laboratories
8.1.6. Research & Academic Institutes
9. Regional Analysis
9.1. North America Skin Cancer Diagnosis and Therapeutics Market Sales Analysis – Cancer Type | Diagnosis Type | Therapeutic Type | End User ($ Million)
• Macroeconomic Factors for North America
9.1.1. United States
9.1.2. Canada
9.2. Europe Skin Cancer Diagnosis and Therapeutics Market Sales Analysis – Cancer Type | Diagnosis Type | Therapeutic Type | End User ($ Million)
• Macroeconomic Factors for Europe
9.2.1. UK
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. France
9.2.6. Rest of Europe
9.3. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Sales Analysis – Cancer Type | Diagnosis Type | Therapeutic Type | End User ($ Million)
• Macroeconomic Factors for Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. ASEAN Economies
9.3.6. Australia and New Zealand
9.3.7. Rest of Asia-Pacific
9.4. Rest of the World Skin Cancer Diagnosis and Therapeutics Market Sales Analysis – Cancer Type | Diagnosis Type | Therapeutic Type | End User ($ Million)
• Macroeconomic Factors for the Rest of the World
9.4.1. Latin America
9.4.2. Middle East and Africa
10. Company Profiles
10.1. Amgen Inc.
10.1.1. Quick Facts
10.1.2. Company Overview
10.1.3. Product Portfolio
10.1.4. Business Strategies
10.2. Bausch Health US, LLC
10.2.1. Quick Facts
10.2.2. Company Overview
10.2.3. Product Portfolio
10.2.4. Business Strategies
10.3. Biocon Biologics Ltd.
10.3.1. Quick Facts
10.3.2. Company Overview
10.3.3. Product Portfolio
10.3.4. Business Strategies
10.4. Bristol-Myers Squibb Co.
10.4.1. Quick Facts
10.4.2. Company Overview
10.4.3. Product Portfolio
10.4.4. Business Strategies
10.5. Castle Biosciences, Inc.
10.5.1. Quick Facts
10.5.2. Company Overview
10.5.3. Product Portfolio
10.5.4. Business Strategies
10.6. DAIICHI SANKYO COMPANY, LTD.
10.6.1. Quick Facts
10.6.2. Company Overview
10.6.3. Product Portfolio
10.6.4. Business Strategies
10.7. DermaSensor, Inc.
10.7.1. Quick Facts
10.7.2. Company Overview
10.7.3. Product Portfolio
10.7.4. Business Strategies
10.8. Elekta
10.8.1. Quick Facts
10.8.2. Company Overview
10.8.3. Product Portfolio
10.8.4. Business Strategies
10.9. Eli Lilly and Co.
10.9.1. Quick Facts
10.9.2. Company Overview
10.9.3. Product Portfolio
10.9.4. Business Strategies
10.10. F. Hoffmann-La Roche Ltd.
10.10.1. Quick Facts
10.10.2. Company Overview
10.10.3. Product Portfolio
10.10.4. Business Strategies
10.11. GlaxoSmithKline plc
10.11.1. Quick Facts
10.11.2. Company Overview
10.11.3. Product Portfolio
10.11.4. Business Strategies
10.12. iCAD, Inc.
10.12.1. Quick Facts
10.12.2. Company Overview
10.12.3. Product Portfolio
10.12.4. Business Strategies
10.13. MediWound
10.13.1. Quick Facts
10.13.2. Company Overview
10.13.3. Product Portfolio
10.13.4. Business Strategies
10.14. Merck & Co., Inc.
10.14.1. Quick Facts
10.14.2. Company Overview
10.14.3. Product Portfolio
10.14.4. Business Strategies
10.15. Novartis AG
10.15.1. Quick Facts
10.15.2. Company Overview
10.15.3. Product Portfolio
10.15.4. Business Strategies
10.16. Pfizer Inc.
10.16.1. Quick Facts
10.16.2. Company Overview
10.16.3. Product Portfolio
10.16.4. Business Strategies
10.17. Regeneron Pharmaceuticals Inc.
10.17.1. Quick Facts
10.17.2. Company Overview
10.17.3. Product Portfolio
10.17.4. Business Strategies
10.18. SANOFI WINTHROP INDUSTRIE
10.18.1. Quick Facts
10.18.2. Company Overview
10.18.3. Product Portfolio
10.18.4. Business Strategies
10.19. Sirnaomics, Inc.
10.19.1. Quick Facts
10.19.2. Company Overview
10.19.3. Product Portfolio
10.19.4. Business Strategies
10.20. SkylineDx B.V.
10.20.1. Quick Facts
10.20.2. Company Overview
10.20.3. Product Portfolio
10.20.4. Business Strategies
10.21. Sun Pharmaceutical Industries Ltd.
10.21.1. Quick Facts
10.21.2. Company Overview
10.21.3. Product Portfolio
10.21.4. Business Strategies
10.22. Teva Pharmaceutical Industries Ltd.
10.22.1. Quick Facts
10.22.2. Company Overview
10.22.3. Product Portfolio
10.22.4. Business Strategies
10.23. Varian Medical Systems, Inc.
10.23.1. Quick Facts
10.23.2. Company Overview
10.23.3. Product Portfolio
10.23.4. Business Strategies
1. Global Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
2. Global Melanoma Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
3. Global Non-Melanoma Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
4. Global Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Diagnosis Type, 2024-2035 ($ Million)
5. Global Dermatoscopy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
6. Global Biopsy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
7. Global Imaging Techniques Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
8. Global Molecular Diagnostics Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
9. Global Blood Tests Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
10. Global Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Therapeutic Type, 2024-2035 ($ Million)
11. Global Surgical Procedures Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
12. Global Radiation Therapy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
13. Global Chemotherapy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
14. Global Targeted Therapy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
15. Global Immunotherapy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
16. Global Photodynamic Therapy Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
17. Global Topical Treatments Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
18. Global Other Cancer Type Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
19. Global Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By End User, 2024-2035 ($ Million)
20. Global Skin Cancer Diagnosis and Therapeutics For Hospitals Market Research And Analysis By Region, 2024-2035 ($ Million)
21. Global Skin Cancer Diagnosis and Therapeutics For Specialty Dermatology Clinics Market Research And Analysis By Region, 2024-2035 ($ Million)
22. Global Skin Cancer Diagnosis and Therapeutics For Cancer Treatment Centers Market Research And Analysis By Region, 2024-2035 ($ Million)
23. Global Skin Cancer Diagnosis and Therapeutics For Ambulatory Surgical Centers Market Research And Analysis By Region, 2024-2035 ($ Million)
24. Global Skin Cancer Diagnosis and Therapeutics For Diagnostic Laboratories Market Research And Analysis By Region, 2024-2035 ($ Million)
25. Global Skin Cancer Diagnosis and Therapeutics For Research & Academic Institutes Market Research And Analysis By Region, 2024-2035 ($ Million)
26. Global Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
27. North American Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Country, 2024-2035 ($ Million)
28. North American Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
29. North American Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Diagnosis Type, 2024-2035 ($ Million)
30. North American Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Therapeutic Type, 2024-2035 ($ Million)
31. North American Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By End User, 2024-2035 ($ Million)
32. European Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Country, 2024-2035 ($ Million)
33. European Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
34. European Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Diagnosis Type, 2024-2035 ($ Million)
35. European Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Therapeutic Type, 2024-2035 ($ Million)
36. European Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By End User, 2024-2035 ($ Million)
37. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Country, 2024-2035 ($ Million)
38. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
39. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Diagnosis Type, 2024-2035 ($ Million)
40. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Therapeutic Type, 2024-2035 ($ Million)
41. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By End User, 2024-2035 ($ Million)
42. Rest Of The World Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Region, 2024-2035 ($ Million)
43. Rest Of The World Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
44. Rest Of The World Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Diagnosis Type, 2024-2035 ($ Million)
45. Rest Of The World Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By Therapeutic Type, 2024-2035 ($ Million)
46. Rest Of The World Skin Cancer Diagnosis and Therapeutics Market Research And Analysis By End User, 2024-2035 ($ Million)
1. Global Skin Cancer Diagnosis and Therapeutics Market Share By Cancer Type, 2024 Vs 2035 (%)
2. Global Melanoma Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
3. Global Non-Melanoma Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
4. Global Skin Cancer Diagnosis and Therapeutics Market Share By Diagnosis Type, 2024 Vs 2035 (%)
5. Global Dermatoscopy Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
6. Global Biopsy Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
7. Global Imaging Techniques Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
8. Global Molecular Diagnostics Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
9. Global Blood Tests Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
10. Global Skin Cancer Diagnosis and Therapeutics Market Share By Therapeutic Type, 2024 Vs 2035 (%)
11. Global Surgical Procedures Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
12. Global Radiation Therapy Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
13. Global Chemotherapy Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
14. Global Targeted Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
15. Global Immunotherapy Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
16. Global Photodynamic Therapy Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
17. Global Topical Treatments Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
18. Global Other Therapeutic Type Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
19. Global Skin Cancer Diagnosis and Therapeutics Market Share By End User, 2024 Vs 2035 (%)
20. Global Skin Cancer Diagnosis and Therapeutics For Hospitals Market Share By Region, 2024 Vs 2035 (%)
21. Global Skin Cancer Diagnosis and Therapeutics For Specialty Dermatology Clinics Market Share By Region, 2024 Vs 2035 (%)
22. Global Skin Cancer Diagnosis and Therapeutics For Cancer Treatment Centers Market Share By Region, 2024 Vs 2035 (%)
23. Global Skin Cancer Diagnosis and Therapeutics For Ambulatory Surgical Centers Market Share By Region, 2024 Vs 2035 (%)
24. Global Skin Cancer Diagnosis and Therapeutics For Diagnostic Laboratories Market Share By Region, 2024 Vs 2035 (%)
25. Global Skin Cancer Diagnosis and Therapeutics For Research & Academic Institutes Market Share By Region, 2024 Vs 2035 (%)
26. Global Skin Cancer Diagnosis and Therapeutics Market Share By Region, 2024 Vs 2035 (%)
27. US Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
28. Canada Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
29. UK Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
30. France Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
31. Germany Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
32. Italy Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
33. Spain Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
34. Russia Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
35. Rest of Europe Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
36. India Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
37. China Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
38. Japan Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
39. South Korea Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
40. Australia and New Zealand Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
41. ASEAN Economies Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
42. Rest of Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
43. Latin America Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
44. Middle East and Africa Skin Cancer Diagnosis and Therapeutics Market Size, 2024–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Skin Cancer Diagnosis and Therapeutics market in 2024 is estimated to be around $14,258 million.
North America holds the largest share in the Skin Cancer Diagnosis and Therapeutics market.
Leading players in the Skin Cancer Diagnosis and Therapeutics market include Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd., among others.
Skin Cancer Diagnosis and Therapeutics market is expected to grow at a CAGR of 5.3% from 2025 to 2035.
Increasing skin cancer incidence, advancements in diagnostic technologies, and rising adoption of targeted therapies are key factors driving market growth.
